LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Jonathan Biller, Executive Vice President and Chief Legal Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), recently executed a significant stock sale. According to a recent SEC filing, Biller ...
Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.
WK Kellogg Co.’s stock fell 1.8% Tuesday after the breakfast-cereal company’s fourth-quarter adjusted profit swept past ...
Since the start of 2025, Oklo Inc. (OKLO) has been on a remarkable rise, catching the attention of investors, analysts, and ...
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...
Nathan Eigerman: The Value Line® Index* represents a higher dividend yield core U.S. equity portfolio. Some investors are ...
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results